Unknown

European pharma just found its growth engine.  It’s not in Europe. Bain quantified what the smartest European mid-sized pharma companies have been executing. 𝟴% 𝗖𝗔𝗚𝗥 𝗼𝘃𝗲𝗿 𝘁𝗵𝗲 𝗹𝗮𝘀𝘁 𝗱…

Uğur Şahin and Özlem Türeci just announced they're leaving BioNTech. Am I the only one getting Yusuf Dikeç vibes from this? The founders' scientific ambitions no longer fit perfectly with the day-to-…

𝗣𝗿𝗶𝘃𝗮𝘁𝗲 𝗘𝗾𝘂𝗶𝘁𝘆 is becoming Pharma’s New Co-Developers via 𝗿𝗼𝘆𝗮𝗹𝘁𝘆 𝗳𝗶𝗻𝗮𝗻𝗰𝗶𝗻𝗴. This 𝗶𝘀𝗻’𝘁 𝘃𝗲𝗻𝘁𝘂𝗿𝗲 𝗰𝗮𝗽𝗶𝘁𝗮𝗹. This 𝗶𝘀𝗻’𝘁 𝗮 𝗹𝗶𝗰𝗲𝗻𝘀𝗶𝗻𝗴 𝗱𝗲𝗮𝗹. T…

UK drug maker AstraZeneca’s CEO warns Europe on missing on new drugs and turning into a mere sales office for the industry. Pascal Soriot warned this week that Germany's plans to cut pharmaceutical s…

Pharma's urgency to replenish its P&Ls has created a void in the market. Nature hates a vacuum. Enter new buyers. Biotechs with rare disease assets under $1-2B USD peak revenue have faced a dead end—…

European pharma just found its growth engine.  It’s not in Europe. Bain quantified what the smartest European mid-sized pharma companies have been executing. 𝟴% 𝗖𝗔𝗚𝗥 𝗼𝘃𝗲𝗿 𝘁𝗵𝗲 𝗹𝗮𝘀𝘁 𝗱…